XML 67 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]  
Future Minimum Annual Lease and Service Payments
As of December 31, 2017, future minimum annual lease and service payments for the Company were as follows:
 
Equipment Leases (a)
 
Service Payments
 
Facility Leases (b)
 
(dollars in thousands)
2018
$
3,511

 
$
21,631

 
$
25,960

2019
1,599

 
10,987

 
21,453

2020
669

 
1,539

 
17,626

2021
639

 
337

 
17,592

2022
420

 

 
11,942

Thereafter

 

 
7,354

 
$
6,838

 
$
34,494

 
$
101,927

(a)
Equipment Leases include the Company's commitments relating to operating and capital leases. See Note 23 for further information on the capital lease minimum payments which are included in the table.
(b)
The Company has entered into various agreements to sublease certain of its premises. The Company recorded sublease income related to these leases of $1.1 million, $2.2 million, and $2.3 million and for the years ended December 31, 2017, 2016, and 2015 respectively.
Other Commitments
The following table summarizes unfunded commitments as of December 31, 2017:
Entity
 
Unfunded Commitments
 
Commitment term
 
 
(dollars in millions)
 
 
Real estate (a)
 
$
19.5

 
(a)
HealthCare Royalty Partners funds (b)
 
6.2

 
2 years
Eclipse Ventures Fund I, L.P. (formerly Formation8 Partners Hardware Fund I, L.P.)
 
0.4

 
7 years
Lagunita Biosciences, LLC
 
2.0

 
3 years
Eclipse Fund II, L.P.
 
0.9

 
8 years
Eclipse Continuity Fund I, L.P.
 
0.6

 
9 years
(a) The Company had unfunded commitments pertaining to capital commitments in six real estate investments held by the Company, all of which pertain to related party investments. Such commitments can be called at any time up to four years, subject to advance notice.
(b) The Company is a limited partner of the HealthCare Royalty Partners funds (which are managed by Healthcare Royalty Management) and is a member of HealthCare Royalty Partners General Partners. The Company will make its pro-rata investment in the HealthCare Royalty Partners funds along with the other limited partners.